Theriva Biologics, Inc. Related Party Transaction, Expenses from Transactions with Related Party
Theriva Biologics, Inc. (TOVX) reported Related Party Transaction, Expenses from Transactions with Related Party of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2022-11-10
- Theriva Biologics, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-09-30 was $0.00.
- Theriva Biologics, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2021-09-30 was $0.00.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 0 month | Related Party Transaction, Expenses from Transactions with Related Party 0 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party | Related Party Transaction, Expenses from Transactions with Related Party as first filed | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 28 month |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||||
| 2020-12-31 | $328.00K 10-Q · filed 2021-11-03 | ||||||
| 2018-09-05 | $441.00K 10-Q · filed 2020-11-10 | $321.00K 10-K · filed 2019-02-27 | $328.00K 10-Q · filed 2022-08-11 | $441.00K 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |